Literature DB >> 21217521

Rapid histochemistry using slow off-rate modified aptamers with anionic competition.

Shashi Gupta1, Derek Thirstrup, Thale C Jarvis, Daniel J Schneider, Sheri K Wilcox, Jeff Carter, Chi Zhang, Amy Gelinas, Allison Weiss, Nebojsa Janjic, Geoffrey S Baird.   

Abstract

Immunohistochemistry is used in both research and clinical settings to identify proteins in tissue samples. Despite the power and versatility of immunohistochemistry, limitations are imposed by the slow diffusion of antibodies through tissue and the need for secondary staining or signal amplification. Aptamers can circumvent these limitations, but their application has been hindered by nonspecific binding to cellular components, particularly in the nucleus. Here we describe unique slow off-rate modified aptamers that facilitate rapid and selective binding to target proteins in tissue. Specifically, we have developed a fluorescent aptamer that binds to the human epidermal growth factor receptor 2 (HER2) in breast carcinomas quickly and specifically, and we have shown that the slow off-rate of the aptamer from the HER2 protein contributes to its selectivity. These findings open the door to aptamer histochemistry applications in both research and clinical settings, including intraoperative diagnostics in which speed and accuracy are paramount.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217521     DOI: 10.1097/PAI.0b013e3182008c29

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  18 in total

Review 1.  Aptahistochemistry in diagnostic pathology: technical scrutiny and feasibility.

Authors:  Bakhtiar A Bukari; Marimuthu Citartan; Ewe Seng Ch'ng; Mawethu P Bilibana; Timofey Rozhdestvensky; Thean-Hock Tang
Journal:  Histochem Cell Biol       Date:  2017-03-20       Impact factor: 4.304

2.  Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets.

Authors:  Douglas R Davies; Amy D Gelinas; Chi Zhang; John C Rohloff; Jeffrey D Carter; Daniel O'Connell; Sheela M Waugh; Steven K Wolk; Wesley S Mayfield; Alex B Burgin; Thomas E Edwards; Lance J Stewart; Larry Gold; Nebojsa Janjic; Thale C Jarvis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-08       Impact factor: 11.205

3.  Influence of 5-N-carboxamide modifications on the thermodynamic stability of oligonucleotides.

Authors:  Steven K Wolk; Richard K Shoemaker; Wes S Mayfield; Andrew L Mestdagh; Nebojsa Janjic
Journal:  Nucleic Acids Res       Date:  2015-10-04       Impact factor: 16.971

Review 4.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

Review 5.  Aptamer in bioanalytical applications.

Authors:  Anton B Iliuk; Lianghai Hu; W Andy Tao
Journal:  Anal Chem       Date:  2011-05-05       Impact factor: 6.986

Review 6.  Aptamers: versatile molecular recognition probes for cancer detection.

Authors:  Hongguang Sun; Weihong Tan; Youli Zu
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

7.  Protein signature of lung cancer tissues.

Authors:  Michael R Mehan; Deborah Ayers; Derek Thirstrup; Wei Xiong; Rachel M Ostroff; Edward N Brody; Jeffrey J Walker; Larry Gold; Thale C Jarvis; Nebojsa Janjic; Geoffrey S Baird; Sheri K Wilcox
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

8.  Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor.

Authors:  Shashi Gupta; Masao Hirota; Sheela M Waugh; Ikuo Murakami; Tomoki Suzuki; Masahiro Muraguchi; Masafumi Shibamori; Yuichi Ishikawa; Thale C Jarvis; Jeffrey D Carter; Chi Zhang; Bharat Gawande; Michael Vrkljan; Nebojsa Janjic; Daniel J Schneider
Journal:  J Biol Chem       Date:  2014-01-12       Impact factor: 5.157

Review 9.  Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents.

Authors:  John C Rohloff; Amy D Gelinas; Thale C Jarvis; Urs A Ochsner; Daniel J Schneider; Larry Gold; Nebojsa Janjic
Journal:  Mol Ther Nucleic Acids       Date:  2014-10-07       Impact factor: 10.183

10.  The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer.

Authors:  Sarah Shigdar; Christine Qian; Li Lv; Chunwen Pu; Yong Li; Lianhong Li; Manju Marappan; Jia Lin; Lifen Wang; Wei Duan
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.